Medical devices, healthcare technology and the business of care
510(k) clearance · K261019

ANTERION

Heidelberg Engineering GmbH · Decision date Sep 11, 2026

MEDTECHLEDGER EXPLANATIONK261019

What did the FDA decide?

The FDA's 510(k) database records K261019 for the device ANTERION, submitted by Heidelberg Engineering GmbH of Heidelberg, Germany, and received on 03/27/2026. The record lists the classification name Tomography, Optical Coherence, regulation number 886.1570, product code OBO, and the Ophthalmic medical specialty and review panel. The submission is a Traditional 510(k); the page states it was not reviewed by a third party, is not a combination product, and has no authorized Predetermined Change Control Plan.

On 09/11/2026 the FDA recorded a decision of Substantially Equivalent (SESE) for K261019. Under the 510(k) pathway this is a clearance finding, not a premarket approval of the device. The page lists clinical trials NCT04083742 and NCT04130490, but the source provides no summary statement, indications for use, or device description, so the specific components or changes reviewed and the basis for the equivalence finding remain unknown from this record.

Regulatory pathway
510(k) premarket notification
Clinical specialty
Ophthalmic
Decision date
Sep 11, 2026

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
K261019
Regulatory pathway
510(k) premarket notification
Product code
OBO
Decision code
SESE
Decision date
Sep 11, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Tomography, Optical Coherence.

Product code
OBO
FDA device class
2

FDA decision timeline

  1. K261019 received

    Application receipt date recorded by FDA.

  2. K261019 · FDA decision

    SESE

Related devices and submissions

Explore the linked device profile

No additional submissions with a verified PMA or product-code relationship are linked here.

Regulatory context

A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Heidelberg Engineering GmbH

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
Heidelberg

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records